BioTelemetry Q3 Adj. EPS $0.52 Beats $0.5 Estimate, Sales $111.3M Beat $111.19M Estimate

BioTelemetry (NASDAQ:BEAT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.5 by 4 percent. This is a 1.89 percent decrease over earnings of $0.53 per share from the same

Benzinga · 11/05/2019 21:24

BioTelemetry (NASDAQ:BEAT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.5 by 4 percent. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $111.3 million which beat the analyst consensus estimate of $111.19 million by 0.10 percent. This is a 11.29 percent increase over sales of $100.013 million the same period last year.